Browse by Section 100 Item List

Highly Specialised Drugs Program (Public Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in public hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies and some of these prescriptions can be dispensed by a community pharmacy. A patient may be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the PBS. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 9558C TACROLIMUStacrolimus 500 microgram capsule, 100 2 200 5
MP 9664P TACROLIMUStacrolimus 500 microgram modified release capsule, 30 2 60 5
MP 9560E TACROLIMUStacrolimus 1 mg capsule, 100 2 200 5
MP 10859M TACROLIMUStacrolimus 750 microgram capsule, 100 2 200 5
MP 10860N TACROLIMUStacrolimus 2 mg capsule, 100 2 200 5
MP 9665Q TACROLIMUStacrolimus 1 mg modified release capsule, 60 2 120 5
MP 9561F TACROLIMUStacrolimus 5 mg capsule, 50 2 100 5
MP 9666R TACROLIMUStacrolimus 5 mg modified release capsule, 30 2 60 5
MP 11907Q TACROLIMUStacrolimus 3 mg modified release capsule, 50 2 100 3
MP 14271D TADALAFILtadalafil 20 mg tablet, 60 1 60 5
MP 14281P TADALAFILtadalafil 20 mg tablet, 60 1 60 5
MP 12151M TADALAFILtadalafil 20 mg tablet, 56 1 56 5
MP 1308W TADALAFILtadalafil 20 mg tablet, 56 1 56 5
MP 11793Q TEDUGLUTIDEteduglutide 5 mg injection [28 vials] (&) inert substance diluent [28 x 0.5 mL syringes], 1 pack 1 28 11
MP 11794R TEDUGLUTIDEteduglutide 5 mg injection [28 vials] (&) inert substance diluent [28 x 0.5 mL syringes], 1 pack 1 28 5
MP 11808L TEDUGLUTIDEteduglutide 5 mg injection [28 vials] (&) inert substance diluent [28 x 0.5 mL syringes], 1 pack 1 28 0
MP 11854X TEZACAFTOR + IVACAFTOR (&) IVACAFTORtezacaftor 100 mg + ivacaftor 150 mg tablet [28] (&) ivacaftor 150 mg tablet [28], 56 1 1 5
MP 11863J TEZACAFTOR + IVACAFTOR (&) IVACAFTORtezacaftor 100 mg + ivacaftor 150 mg tablet [28] (&) ivacaftor 150 mg tablet [28], 56 1 1 5
MP 9667T THALIDOMIDEthalidomide 100 mg capsule, 28 2 56 0
MP 9566L THALIDOMIDEthalidomide 50 mg capsule, 28 4 112 0
MP 10056G TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 1 1 0
MP 10058J TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 1 1 0
MP 12791F TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 1 1 0
MP 12796L TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 1 1 0
MP 13305G TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 1 1 5
MP 13330N TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 2 2 5
MP 13684F TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 1 1 5
MP 1481Y TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 1 1 0
MP 9658H TOCILIZUMABtocilizumab 200 mg/10 mL injection, 10 mL vial 1 1 0
MP 10064Q TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 1 1 0
MP 10072D TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 1 1 0
MP 12763R TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 1 1 0
MP 12802T TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 1 1 0
MP 13299Y TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 2 2 5
MP 13339C TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 1 1 5
MP 13715W TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 1 1 5
MP 1482B TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 1 1 0
MP 9659J TOCILIZUMABtocilizumab 400 mg/20 mL injection, 20 mL vial 1 1 0
MP 10077J TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 1 1 0
MP 10081N TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 1 1 0
MP 12775J TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 1 1 0
MP 12794J TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 1 1 0
MP 13304F TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 4 4 5
MP 13324G TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 2 2 5
MP 13690M TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 2 2 5
MP 1476Q TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 1 1 0
MP 9657G TOCILIZUMABtocilizumab 80 mg/4 mL injection, 4 mL vial 1 1 0